Levofloxacin Baxter

Levofloxacin, the active ingredient in Levofloxacin Baxter, is a fluoroquinolone presented as an intravenous injection for IV use. It is employed to treat a variety of serious bacterial infections in adult and pediatric patients when prescribed by a qualified healthcare professional. The drug is supplied in a sterile solution suitable for infusion over a controlled period, ensuring rapid systemic exposure.

GNH USA supplies Levofloxacin Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory documentation, cold‑chain logistics, and post‑delivery support to meet global quality standards.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections affecting several organ systems.

Community-acquired pneumonia: reduces bacterial load, leading to clinical recovery and prevention of complications. Complicated urinary tract infections: eradicates causative pathogens, facilitating resolution of infection and preservation of renal function. Skin and soft tissue infections: provides rapid bacterial clearance, promoting wound healing and symptom relief. Acute bacterial sinusitis: eliminates sinus pathogens, improving sinus drainage and relieving congestion. Acute bacterial prostatitis: targets prostate‑resident bacteria, achieving symptom improvement and microbiological cure.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Insomnia - Rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation - Clostridioides difficile‑associated diarrhea - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Peripheral neuropathy - Hepatic enzyme elevation

Before initiating levofloxacin therapy, clinicians should consider several safety precautions to minimize risk.

- Assess renal function: adjust dose in patients with impaired clearance. - Monitor for tendon injury: advise patients to report tendon pain or swelling. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use caution with QT‑prolonging conditions: obtain baseline ECG when risk factors exist. - Adjust dose in elderly: consider reduced dosing or increased monitoring. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids or supplements containing aluminum, magnesium, calcium, or iron (reduce absorption). - Amiodarone (increases QT prolongation risk). - Warfarin (enhances anticoagulant effect). - Theophylline (increases toxicity). - Cyclosporine (elevates serum levels).

Moderate Interactions (Monitor Closely): - NSAIDs (increase CNS toxicity). - Corticosteroids (higher tendon rupture risk). - Oral contraceptives (reduced effectiveness). - SSRIs (additive QT risk). - Diabetic agents (potential hypoglycemia).